Literature DB >> 25234636

Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome.

Kathrin Buder1, Beatrice Latal, Samuel Nef, Thomas J Neuhaus, Guido F Laube, Giuseppina Spartà.   

Abstract

BACKGROUND: To investigate the long-term neurodevelopmental outcome in children after hemolytic uremic syndrome (HUS) and to compare outcome dependent on central nervous system (CNS) involvement during HUS.
METHODS: A single-center retrospective cohort of 47 children was examined at a median age of 10.6 (range 6-16.9) years and a median follow-up of 7.8 (range 0.4-15.3) years after having had HUS. Intellectual performance was assessed with the German version of the Wechsler Intelligence Scale 4th version and neuromotor performance with the Zurich Neuromotor Assessment (ZNA). The occurrence of neurological symptoms during the acute phase of HUS was evaluated retrospectively.
RESULTS: Mean IQ of the whole study population fell within the normal range (median full scale IQ 104, range 54-127). Neuromotor performance was significantly poorer in the domains "adaptive fine," "gross motor," "static balance" (all p < 0.05) and "associated movements" (p < 0.001); only the "pure motor" domain was within the normal reference range. Neurological findings occurred in 16/47 patients (34 %) during acute HUS. Neurodevelopmental outcome was not significantly different between children with or without CNS involvement.
CONCLUSIONS: Our follow-up of children after HUS showed a favorable cognitive outcome. However, neuromotor outcome was impaired in all study participants. Neurological impairment during acute HUS was not predictive of outcome.

Entities:  

Mesh:

Year:  2014        PMID: 25234636     DOI: 10.1007/s00467-014-2950-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

Review 1.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 2.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

Review 3.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

4.  Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement.

Authors:  Frank Donnerstag; Xiaoqi Ding; Lars Pape; Eva Bültmann; Thomas Lücke; Jan Zajaczek; Ludwig Hoy; Anibh Martin Das; Heinrich Lanfermann; Jochen Ehrich; Hans Hartmann
Journal:  Eur Radiol       Date:  2011-10-08       Impact factor: 5.315

5.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

6.  Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America.

Authors:  Ritu Banerjee; Adam L Hersh; Jason Newland; Susan E Beekmann; Philip M Polgreen; Jeffrey Bender; Jana Shaw; Lawrence Copelovitch; Bernard S Kaplan; Samir S Shah
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

7.  Long-term motor and cognitive outcome in children with congenital diaphragmatic hernia.

Authors:  Isabell Tureczek; Jon Caflisch; Ulrich Moehrlen; Giancarlo Natalucci; Vera Bernet; Beatrice Latal
Journal:  Acta Paediatr       Date:  2012-01-09       Impact factor: 2.299

8.  Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy.

Authors:  Rebecca J Johnson; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2013-04-04       Impact factor: 3.714

Review 9.  Acute kidney injury in children.

Authors:  Sharon Phillips Andreoli
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

Review 10.  Streptococcus pneumoniae-associated hemolytic uremic syndrome.

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2007-06-13       Impact factor: 3.714

View more
  11 in total

1.  Evaluation of enzyme immunoassays and real-time PCR for detecting Shiga toxin-producing Escherichia coli in Southern Alberta, Canada.

Authors:  Linda Chui; Laura Patterson-Fortin; Julie Kuo; Vincent Li; Valerie Boras
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

2.  Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.

Authors:  Takeshi Ninchoji; Kandai Nozu; Keita Nakanishi; Tomoko Horinouchi; Junya Fujimura; Tomohiko Yamamura; Shogo Minamikawa; Shingo Ishimori; Koichi Nakanishi; Norishige Yoshikawa; Ichiro Morioka; Hiroshi Kaito; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2017-01-10       Impact factor: 2.801

3.  Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Hitoshi Irabu; Maiko Takakura; Hisashi Kaneda; Naotoshi Sugimoto; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2017-03-10       Impact factor: 2.801

4.  Long-term health-related quality of life and psychological adjustment in children after haemolytic-uraemic syndrome.

Authors:  Helene Werner; Kathrin Buder; Markus A Landolt; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2016-12-23       Impact factor: 3.714

5.  Health-related quality of life and mental health in parents of children with hemolytic uremic syndrome.

Authors:  Kathrin Buder; Helene Werner; Markus A Landolt; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2015-12-23       Impact factor: 3.714

6.  Steroid Pulse Therapy for Severe Central Nervous System Involvement in Shiga Toxin-Producing Escherichia coli-Related Hemolytic Uremic Syndrome.

Authors:  Chiara Rosazza; Alberto M Cappellari; Cristiano Gandini; Elisa Scola; Gianluigi Ardissino
Journal:  Case Rep Pediatr       Date:  2021-05-15

Review 7.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

8.  Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic Escherichia coli induced hemolytic uremic syndrome.

Authors:  Yuko Tasaki; Natsumi Inoue; Masaki Shimizu; Naotoshi Sugimoto; Sayaka Ishikawa; Mao Mizuta; Tadafumi Yokoyama; Mondo Kuroda; Kazuhide Ohta; Akihiro Yachie; Taizo Wada
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

9.  Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.

Authors:  Gaute Reier Jenssen; Line Vold; Eirik Hovland; Hans-Jacob Bangstad; Karin Nygård; Anna Bjerre
Journal:  BMC Infect Dis       Date:  2016-06-13       Impact factor: 3.090

Review 10.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.